Rapamycin Sensitivity in Saccharomyces cerevisiae Is Mediated by a Peptidyl-Prolyl cis-trans Isomerase Related to Human FK506-Binding Protein

REFERENCES

• Bailis, A. M., and R. Rothstein. 1990. A defect in mismatch repair in Saccharomyces cerevisiae stimulates ectopic recombination between homologous genes by an excision repair dependent process. Genetics 126:535-547.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
   PubMed Web of Science ®Google Scholar
• Calne, R. Y., D. S. Collier, S. Lin, S. G. Pollard, A. Saman, D. J. White, and S. Thiru. 1989. Rapamycin for immunosuppression in organ allografting. Lancet ii:227.
   Google Scholar
• Cha, S. 1975. Tight-binding inhibitors. I. Kinetic behavior. Biochem. Pharmacol. 24:2177-2185.
   PubMed Web of Science ®Google Scholar
• Clements, J., T. Laz, and F. Sherman. 1987. The role of yeast mRNA sequences and structures in translation, p. 65-82. In P. J. Barr, A. J. Brake, and P. Valenzuela (ed.), Yeast genetic engineering. Butterworths, Boston.
   Google Scholar
• Dumont, F. J., M. R. Melino, M. J. Staruch, S. L. Koprak, P. A. Fischer, and N. H. Sigal. 1990. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J. Immunol. 144:1418-1424.
   PubMed Web of Science ®Google Scholar
• Dumont, F. J., M. J. Staruch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144:251-258.
   PubMed Web of Science ®Google Scholar
• Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacey, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617-1620.
   PubMed Web of Science ®Google Scholar
• Eng, C. P., S. N. Sehgal, and C. Vezina. 1984. Activity of rapamycin (AY-22,989) against transplanted tumors. J. Antibiot. 37:1231-1237.
   PubMed Web of Science ®Google Scholar
• Eng, W.-K., L. Faucette, R. K. Johnson, and R. Sternglanz. 1988. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34:755-760.
   PubMed Web of Science ®Google Scholar
• Fisher, G., H. Bang, and C. Mech. 1984. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline containing peptides as substrates. Biomed. Biochim. Acta 43:1101-1112.
   PubMedGoogle Scholar
• Fisher, G., B. Wittmann-Liebold, K. Lang, T. Kiefhaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (London) 337:476-478.
   PubMedGoogle Scholar
• Haendler, B., R. Keller, P. C. Hiestand, H. P. Kocher, G. Wegmann, and N. Rao Mowa. 1989. Yeast cyclophilin: isolation and characterization of the protein, cDNA and gene. Gene 83:39-46.
   PubMedGoogle Scholar
• Hamilton, R., C. K. Wantanabe, and H. A. de Boer. 1987. Compilation and comparison of the sequence context around the AUG startcodons in Saccharomyces cerevisiae mRNAs. Nucleic Acids Res. 15:3581-3593.
   PubMed Web of Science ®Google Scholar
• Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber. 1989. A receptor for the immunosuppressant FK506 is a cistrans peptidyl-prolyl isomerase. Nature (London) 341:758-760.
   PubMed Web of Science ®Google Scholar
• Harrison, R. K., and R. L. Stein. 1990. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. Biochemistry 29:2813-2816.
   Google Scholar
• Hill, J. E., A. M. Myers, T. J. Koerner, and A. Tzagoloff. 1986. Yeast/E. coli shuttle vectors with multiple unique restriction sites. Yeast 2:163-167.
   PubMed Web of Science ®Google Scholar
• Houchens, D. P., A. A. Ovejera, S. M. Riblet, and D. E. Slagel. 1983. Human brain tumor xenografts in nude mice as a chemotherapy model. Eur. J. Cancer Clin. Oncol. 19:799-805.
   PubMedGoogle Scholar
• Kahan, B. D. (ed.). 1988. Second International Congress on Cyclosporin A. Transplant. Proc. vol. 20, Suppl. 2.
   Google Scholar
• Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Gott, M. Okuhara, M. Kohsaka, H. Aoki, and M. Imanaka. 1987. FK506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation and physiochemical and biological characteristics. J. Antibiot. 40:1249-1255.
   PubMed Web of Science ®Google Scholar
• Koser, P. L., D. Sylvester, G. P. Livi, and D. J. Bergsma. 1990. A second cyclophilin-related gene in Saccharomyces cerevisiae. Nucleic Acids Res. 18:1643.
   PubMedGoogle Scholar
• Larkin, J. C., J. R. Thompson, and J. L. Woolford. 1987. Structure and expression of the Saccharomyces cerevisiae CRY1 gene: a highly conserved ribosomal protein gene. Mol. Cell. Biol. 7:1764-1775.
   PubMedGoogle Scholar
• Levy, M. A., and M. Brandt. Unpublished data.
   Google Scholar
• Liu, J., and C. T. Walsh. 1990. Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A. Proc. Natl. Acad. Sci. USA 87:4028-4032.
   PubMed Web of Science ®Google Scholar
• Livi, G. P., J. B. Hicks, and A. J. S. Klar. 1990. The suml-1 mutation affects silent mating type gene transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 10:409-412.
   PubMedGoogle Scholar
• Maki, N., F. Sekiguchi, J. Nishimaki, K. Miwa, T. Hayano, N. Takahashi, and M. Suzuki. 1990. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. Proc. Natl. Acad. Sci. USA 87:5440-5443.
   PubMed Web of Science ®Google Scholar
• Martel, R. R., J. Klicius, and S. Galet. 1977. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can. J. Physiol. Pharmacol. 55:48-51.
   PubMed Web of Science ®Google Scholar
• Mullis, K. B., and F. A. Faloona. 1987. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155:335-350.
   PubMed Web of Science ®Google Scholar
• Nitiss, J., and J. C. Wang. 1988. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA 85:7501-7505.
   PubMed Web of Science ®Google Scholar
• Rose, M. D., P. Novick, J. H. Thomas, D. Botstein, and G. R. Fink. 1987. A Saccharomyces cerevisiae genomic plasmid bank based on a centromere containing shuttle vector. Gene 60:237-243.
   PubMed Web of Science ®Google Scholar
• Rothstein, R. J. 1983. One-step gene disruption in yeast. Methods Enzymol. 101:202-211.
   PubMed Web of Science ®Google Scholar
• Sawada, S., G. Suzuki, Y. Kawase, and F. Takaku. 1987. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J. Immunol. 139:1797-1803.
   PubMed Web of Science ®Google Scholar
• Seghal, S. N., H. Baker, and C. Vezina. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. 28:727-732.
   PubMedGoogle Scholar
• Shatzman, A. R., and M. Rosenberg. 1987. The pAS vector system and its application to heterologous gene expression in Escherichia coli. Hepatology 7:30S-35S.
   PubMedGoogle Scholar
• Siekierka, J. J., S. H. Y. Hung, M. Poe, C. S. Lin, and N. H. Sigal. 1989. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (London) 341:755-757.
   PubMed Web of Science ®Google Scholar
• Standaert, R. F., A. Galat, G. L. Verdine, and S. L. Schreiber. 1990. Molecular cloning and the overexpression of the human FK506-binding protein FKBP. Nature (London) 346:671-674.
   PubMed Web of Science ®Google Scholar
• Starzl, T. E., S. Tudo, J. J. Fung, and C. Groth (ed.). 1990. Second International Workshop on FK506. Transplant. Proc. vol. 22, no. 1.
   Google Scholar
• Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature (London) 337:473-475.
   PubMed Web of Science ®Google Scholar
• Thompson, A. W., and J. Woo. 1989. Immunosuppressive properties of FK506 and rapamycin. Lancet ii:443-444.
   Google Scholar
• Thrash, C., A. T. Bankier, B. G. Barrell, and R. Sternglanz. 1985. Cloning, characterization and sequence of the yeast DNA topoisomerase I gene. Proc. Natl. Acad. Sci. USA 82:4374-4378.
   PubMedGoogle Scholar
• Tropschug, M., I. B. Barthelemess, and W. Neupert. 1989. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae. Nature (London) 342:953-955.
   PubMedGoogle Scholar
• Tropschug, M., E. Wachter, S. Mayer, E. R. Schonbrunner, and F. X. Schmid. 1990. Isolation and sequence of an FK506-binding protein from N. crassa which catalyzes protein folding. Nature (London) 346:674-677.
   PubMed Web of Science ®Google Scholar
• Vezina, C., A. Kudelski, and S. N. Sehgal. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28:721-726.
   PubMed Web of Science ®Google Scholar